Peer-reviewedCC BYJournal of cardiovascular development and disease1 Oct 2026

Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation

Andrea Matteucci¹
Michela Bonanni²
Luca Sgarra³
Lorenzo Nesti⁴
Marco Valerio Mariani⁵
Nicola Pierucci⁵
Angelica Cersosimo⁶
Raimondo Pittorru⁷
Federico Nardi⁸
Furio Colivicchi¹

8 affiliations

¹Clinical and Rehabilitation Cardiology Division, San Filippo Neri Hospital, 00135 Rome, Italy
²Department of Cardiology, Tor Vergata University, 00133 Rome, Italy
³Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, , 00185 Rome, Italy
⁴Department of Cardiology, Regional General Hospital “F. Miulli”, 70021 Bari, Italy;
⁵Cardiopulmonary Laboratory, Department of Clinical and Experimental Medicine, , 56126 Pisa, Italy
⁶Department of Experimental and Clinical Medicine, , 88100 Catanzaro, Italy
⁷Department of Cardiac, Thoracic Vascular Sciences and Public Health, , 35121 Padova, Italy;
⁸Santo Spirito Hospital, Casale Monferrato, 15033 Alessandria, Italy

Read full text PDF Cite

Substrate Comprising Fibrosis and Epicardial Adipose Tissue-Associated Electrophysiological Remodeling Can Sustain Atrial Fibrillation Drivers: Insights from Image-Personalized Computational Simulations
Yaacoub Chahine, Heather Wood, Åshild Telle +9
Heart rhythm9 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicinePMC
Thirty years of percutaneous epicardial access: reflections on the evolution of ventricular tachycardia substrate mapping and ablation
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology1 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Epicardial adipose tissue in obesity-related heart failure with preserved ejection fraction and atrial fibrillation: mechanisms, imaging, and therapeutic modulation
Qi Zhu, Tiance Xu, Chen Yang +1
Frontiers in endocrinology9 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMCCrossref
Association of epicardial adipose tissue with circulating biomarkers in paroxysmal atrial fibrillation: insights from the RACE V study
Michelle Lobeek, Dawid K Baron, Just Dronkers +11
Open Heart2 Nov 2026Peer-reviewedCC BY-NC 4.0Full textCardiovascular medicinePMC
Cardiometabolic therapy for rhythm control: a case report of refractory atrial fibrillation resolving after initiation of semaglutide for obesity
European heart journal. Case reports28 Sep 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@article{matteucci2026cardiometabolic,
  title = {{Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation}},
  author = {Andrea Matteucci and Michela Bonanni and Luca Sgarra and Lorenzo Nesti and Marco Valerio Mariani and Nicola Pierucci and Angelica Cersosimo and Raimondo Pittorru and Federico Nardi and Furio Colivicchi},
  journal = {Journal of cardiovascular development and disease},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13705219},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation
AU  - Andrea Matteucci
AU  - Michela Bonanni
AU  - Luca Sgarra
AU  - Lorenzo Nesti
AU  - Marco Valerio Mariani
AU  - Nicola Pierucci
AU  - Angelica Cersosimo
AU  - Raimondo Pittorru
AU  - Federico Nardi
AU  - Furio Colivicchi
PY  - 2026
DA  - 2026/10/01
JO  - Journal of cardiovascular development and disease
UR  - https://europepmc.org/article/PMC/PMC13705219
SN  - 2308-3425
ER  -

Related

Cite